The UN, WHO, and UNICEF have all called for a "polio pause" to the hostilities in the Gaza Strip to allow hundreds of thousands of children to be vaccinated against the virus.
The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.